Merz Venture Initiative
Corporate venture profile
Merz Venture Initiative is the corporate venture arm of Merz Pharma, a pharmaceutical and biotech company. It invests at the Series A stage. Sectors it names: medical devices, biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series A to Series A |
| Sectors | Medical devices, Biotech and life sciences |
| Geography | Global |
Sources: S1 Merz Venture Initiative.
Key facts
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2024-01-31 | Acorn Biolabs | Series A | USD 8M | Yes | S4 |
Portfolio
Portfolio companies named in public sources: Cytrellis Biosystems, Acorn Biolabs.S3
Official pages
Read the firm's own pages for current information.
- Website www.merz.com/venture-initiative/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Merz Venture Initiative or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.